Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1991 1
1993 2
1994 1
1995 2
1996 2
1997 4
1999 4
2000 1
2001 3
2002 3
2003 3
2004 1
2006 1
2010 3
2011 2
2012 3
2013 1
2014 1
2015 3
2016 1
2017 1
2018 5
2019 4
2020 4
2021 7
2022 5
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

64 results
Results by year
Filters applied: . Clear all
Page 1
Potential Therapeutic Use of Aptamers against HAT1 in Lung Cancer.
Klett-Mingo JI, Pinto-Díez C, Cambronero-Plaza J, Carrión-Marchante R, Barragán-Usero M, Pérez-Morgado MI, Rodríguez-Martín E, Toledo-Lobo MV, González VM, Martín ME. Klett-Mingo JI, et al. Among authors: rodriguez martin e. Cancers (Basel). 2022 Dec 30;15(1):227. doi: 10.3390/cancers15010227. Cancers (Basel). 2022. PMID: 36612223 Free PMC article.
The role of astroglia on the survival of dopamine neurons.
Mena MA, de Bernardo S, Casarejos MJ, Canals S, Rodríguez-Martín E. Mena MA, et al. Among authors: rodriguez martin e. Mol Neurobiol. 2002 Jun;25(3):245-63. doi: 10.1385/MN:25:3:245. Mol Neurobiol. 2002. PMID: 12109874 Review.
Factors associated with dimethyl fumarate-induced lymphopenia.
Sainz de la Maza S, Medina S, Villarrubia N, Costa-Frossard L, Monreal E, Tejeda-Velarde A, Rodríguez-Martín E, Roldán E, Álvarez-Cermeño JC, Villar LM. Sainz de la Maza S, et al. Among authors: rodriguez martin e. J Neurol Sci. 2019 Mar 15;398:4-8. doi: 10.1016/j.jns.2019.01.007. Epub 2019 Jan 8. J Neurol Sci. 2019. PMID: 30658226
Baseline Inflammatory Status Reveals Dichotomic Immune Mechanisms Involved In Primary-Progressive Multiple Sclerosis Pathology.
Fernández-Velasco JI, Monreal E, Kuhle J, Meca-Lallana V, Meca-Lallana J, Izquierdo G, Oreja-Guevara C, Gascón-Giménez F, Sainz de la Maza S, Walo-Delgado PE, Lapuente-Suanzes P, Maceski A, Rodríguez-Martín E, Roldán E, Villarrubia N, Saiz A, Blanco Y, Diaz-Pérez C, Valero-López G, Diaz-Diaz J, Aladro Y, Brieva L, Íñiguez C, González-Suárez I, Rodríguez de Antonio LA, García-Domínguez JM, Sabin J, Llufriu S, Masjuan J, Costa-Frossard L, Villar LM. Fernández-Velasco JI, et al. Among authors: rodriguez martin e. Front Immunol. 2022 Mar 21;13:842354. doi: 10.3389/fimmu.2022.842354. eCollection 2022. Front Immunol. 2022. PMID: 35386690 Free PMC article.
The inhibition of NCS-1 binding to Ric8a rescues fragile X syndrome mice model phenotypes.
Cogram P, Fernández-Beltrán LC, Casarejos MJ, Sánchez-Yepes S, Rodríguez-Martín E, García-Rubia A, Sánchez-Barrena MJ, Gil C, Martínez A, Mansilla A. Cogram P, et al. Among authors: rodriguez martin e. Front Neurosci. 2022 Nov 16;16:1007531. doi: 10.3389/fnins.2022.1007531. eCollection 2022. Front Neurosci. 2022. PMID: 36466176 Free PMC article.
Successful Desensitization to Daratumumab After a Severe Life-threatening Reaction in a Patient With Refractory Multiple Myeloma.
Carrón-Herrero A, Solano-Solares E, Geraldine Rita C, Rodríguez-Martín E, Ruedas A, Barbolla I, Berges-Gimeno MP. Carrón-Herrero A, et al. Among authors: rodriguez martin e. J Investig Allergol Clin Immunol. 2021 Dec 21;31(6):511-513. doi: 10.18176/jiaci.0678. Epub 2020 Feb 5. J Investig Allergol Clin Immunol. 2021. PMID: 33541850 Free article. No abstract available.
B-lymphocyte-guided retreatment contributes to establish good effectiveness and safety profile in MS patients treated with rituximab.
Chico-García JL, Rodríguez-Jorge F, Sainz-Amo R, Monreal E, Walo-Delgado P, Roldán E, Rodríguez-Martín E, Masjuan J, Costa-Frossard L, Sainz de la Maza S, Villar LM. Chico-García JL, et al. Among authors: rodriguez martin e. Mult Scler Relat Disord. 2022 Dec;68:104218. doi: 10.1016/j.msard.2022.104218. Epub 2022 Oct 8. Mult Scler Relat Disord. 2022. PMID: 36270253
Effect of Ocrelizumab in Blood Leukocytes of Patients With Primary Progressive MS.
Fernández-Velasco JI, Kuhle J, Monreal E, Meca-Lallana V, Meca-Lallana J, Izquierdo G, Gascón-Giménez F, Sainz de la Maza S, Walo-Delgado PE, Maceski A, Rodríguez-Martín E, Roldán E, Villarrubia N, Saiz A, Blanco Y, Sánchez P, Carreón-Guarnizo E, Aladro Y, Brieva L, Íñiguez C, González-Suárez I, Rodríguez de Antonio LA, Masjuan J, Costa-Frossard L, Villar LM. Fernández-Velasco JI, et al. Among authors: rodriguez martin e. Neurol Neuroimmunol Neuroinflamm. 2021 Jan 6;8(2):e940. doi: 10.1212/NXI.0000000000000940. Print 2021 Mar 4. Neurol Neuroimmunol Neuroinflamm. 2021. PMID: 33408167 Free PMC article.
Role of B Cell Profile for Predicting Secondary Autoimmunity in Patients Treated With Alemtuzumab.
Walo-Delgado PE, Monreal E, Medina S, Quintana E, Sainz de la Maza S, Fernández-Velasco JI, Lapuente P, Comabella M, Ramió-Torrentà L, Montalban X, Midaglia L, Villarrubia N, Carrasco-Sayalero A, Rodríguez-Martín E, Roldán E, Meca-Lallana J, Alvarez-Lafuente R, Masjuan J, Costa-Frossard L, Villar LM. Walo-Delgado PE, et al. Among authors: rodriguez martin e. Front Immunol. 2021 Oct 8;12:760546. doi: 10.3389/fimmu.2021.760546. eCollection 2021. Front Immunol. 2021. PMID: 34691084 Free PMC article. Clinical Trial.
[The morning after pill, a necessary scientific discussion].
Alegre-Del Rey EJ, Fénix-Caballero S, Díaz-Navarro J, Rodríguez-Martín E. Alegre-Del Rey EJ, et al. Among authors: rodriguez martin e. Gac Sanit. 2016 Sep-Oct;30(5):401-2. doi: 10.1016/j.gaceta.2016.04.024. Epub 2016 Jun 18. Gac Sanit. 2016. PMID: 27329011 Free article. Spanish. No abstract available.
64 results